ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements
Coral Laboratories Ltd's board approved the Cost Audit Report for fiscal year 2025-26. This routine meeting involved no other material financial or business decisions.
Coral Laboratories intimated BSE of a board meeting scheduled for 25 September 2026. The agenda includes approval of the cost audit report for FY 2025-26.
Coral Laboratories Limited has issued a notice for its Annual General Meeting scheduled for June 29, 2026. Agenda items include adoption of financial statements and dividend declaration.
Coral Laboratories Limited has released its Annual Report for FY 2025-26. The 44th Annual General Meeting is scheduled for September 29, 2026, via video conferencing.
Coral Laboratories Ltd reported revenue from operations of ₹29.6 Cr (+57.4% YoY) and net profit of ₹5.4 Cr (+107.7% YoY) for Q1 FY27.
Coral Laboratories Ltd reported revenue from operations of ₹26.5 Cr (-5.7% YoY) and net profit of ₹5.2 Cr (+85.7% YoY) for Q4 FY26.